The University of Chicago Header Logo

Connection

Arlene Chapman to Half-Life

Back to Details
This is a "connection" page, showing publications Arlene Chapman has written about Half-Life.
Arlene Chapman
Connection Strength
0.037
Half-Life
  1. Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial. J Clin Pharmacol. 2017 07; 57(7):906-917.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.